Related references
Note: Only part of the references are listed.Targeted Immunotherapy for High-Risk Neuroblastoma-The Role of Monoclonal Antibodies
Kerry Parsons et al.
ANNALS OF PHARMACOTHERAPY (2013)
Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma.
Alice L. Yu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study
Katherine K. Matthay et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Immunotoxicity of monoclonal antibodies
Jacques Descotes
MABS (2009)
Neuroblastoma: Biological insights into a clinical enigma
GM Brodeur
NATURE REVIEWS CANCER (2003)
Ocular symptoms in children treated with human-mouse chimeric anti-GD2 mAb ch14.18 for neuroblastoma
B Kremens et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2002)
Share Paper
